Dexcel Pharma Technologies Ltd.

Israel · Reporting entity ID 100000141541

Total reported 2019–2025

$66K

#2,272 of 2,960 reporting companies — 0% of all reported industry payments

$37K in general payments across 936 records, plus $29K in research funding across 5 records.

How it breaks down

General payments $36,905

Research funding $28,780

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.